BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Vitamin E
,
rs2300478
,
MYC
,
T cell receptor signaling pathway
,
Breast Cancer
,
Lung
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Musashi 2
Summary
General Info
Curated Studies
Most Correlated Studies
Musashi-2 HITS-CLIP sequencing in K562 cells
Hematopoetic stem cell gene expression regulated by Musashi 2 (Msi2)
RIP-Chip analysis of Musashi (Msi1)
Breast adenocarcinoma MCF7 cells with siRNA knockdown of the musashi RNA-binding protein 2 (MSI2)
Pancreatic carcinoma MIA PaCa-2 cells with combinations of MSI1 and MSI2 shRNA knockdowns
Explore Curated Studies Results
Literature
Most Relevant Literature
Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma.
Msi2-mediated MiR7a-1 processing repression promotes myogenesis.
MSI2 deficiency in ILC3s attenuates DSS-induced colitis by affecting the intestinal microbiota.
Myofibroblast-Specific Msi2 Knockout Inhibits HCC Progression in a Mouse Model.
The Musashi proteins MSI1 and MSI2 are required for photoreceptor morphogenesis and vision in mice.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151…
A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in P…
Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer
Japan Phase 2 Study of Niraparib in Patients With Advanced, Relapsed Ovarian Cancer
Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Tri…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ